|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print September 13, 2005
Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY 10595
Corresponding Author: yuk-ching_tse-dinh{at}nymc.edu
DNA topoisomerases are important clinical targets for antibacterial and anticancer therapy. At least one type IA DNA topoisomerases can be found in every bacterium, making it a logical target for antibacterial agents that can convert the enzyme into poison by trapping its covalent complex with DNA. However, it has not been possible previously to observe the consequence of having such stabilized covalent complex of bacterial topoisomerase I in vivo. We isolated a mutant of recombinant Yersinia pestis topoisomerase I that forms a stabilized covalent complex with DNA by screening for the ability to induce the SOS response in Escherichia coli. Overexpression of this mutant topoisomerase I resulted in bacterial cell death. From sequence analysis and site-directed mutagenesis, it was determined that a single amino acid substitution in the TOPRIM domain changing a strictly conserved glycine residue to serine in either the Y. pestis or E. coli topoisomerase I can result in a mutant enzyme that has the SOS inducing and cell killing properties. Analysis of the purified mutant enzymes showed that they have no relaxation activity but retain the ability to cleave DNA and form a covalent complex. These results demonstrate that perturbation of the active site region of bacterial topoisomerase I can result in stabilization of the covalent intermediate, with the in vivo consequence of bacterial cell death. Small molecules that induce similar perturbation in the enzyme-DNA complex should be candidates as leads for novel antibacterial agents.
J. Biol. Chem, 10.1074/jbc.M509722200
Submitted on September 2, 2005
Revised on September 8, 2005
Accepted on September 13, 2005
Bacterial cell killing mediated by topoisomerase I DNA cleavage activity
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  Y.-C. Tse-Dinh Bacterial topoisomerase I as a target for discovery of antibacterial compounds Nucleic Acids Res., November 28, 2008; (2008) gkn936v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Sorokin, B. Cheng, S. Rathi, S. J. Aedo, M. V. Abrenica, and Y.-C. Tse-Dinh Inhibition of Mg2+ binding and DNA religation by bacterial topoisomerase I via introduction of an additional positive charge into the active site region Nucleic Acids Res., August 1, 2008; 36(14): 4788 - 4796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Sutherland, B. Cheng, I-F. Liu, and Y.-C. Tse-Dinh SOS Induction by Stabilized Topoisomerase IA Cleavage Complex Occurs via the RecBCD Pathway J. Bacteriol., May 1, 2008; 190(9): 3399 - 3403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Cheng, E. P. Sorokin, and Y.-C. Tse-Dinh Mutation adjacent to the active site tyrosine can enhance DNA cleavage and cell killing by the TOPRIM Gly to Ser mutant of bacterial topoisomerase I Nucleic Acids Res., February 11, 2008; 36(3): 1017 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Cheng, I-F. Liu, and Y.-C. Tse-Dinh Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I J. Antimicrob. Chemother., April 1, 2007; 59(4): 640 - 645. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |